XBiotech
XBIT
XBIT
52 hedge funds and large institutions have $10.1M invested in XBiotech in 2025 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 12 increasing their positions, 19 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
52
Holders Change
-3
Holders Change %
-5.45%
% of All Funds
0.7%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
12
Reduced
19
Closed
18
Calls
–
Puts
$3K
Net Calls
-$3K
Net Calls Change
-$3K
Top Buyers
| 1 |
Millennium Management
New York
|
+$1.39M |
| 2 |
RC
RBF Capital
San Francisco,
California
|
+$594K |
| 3 |
Goldman Sachs
New York
|
+$193K |
| 4 |
YIH
Y-Intercept (HK)
Hong Kong
|
+$142K |
| 5 |
Squarepoint
New York
|
+$118K |
Top Sellers
| 1 |
BlackRock
New York
|
-$2.71M |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
-$715K |
| 3 |
State Street
Boston,
Massachusetts
|
-$479K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$349K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$345K |
